Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DIGOXIN 125 MCG TABLET

Digoxin
$0.1173per EA

Strength

125 ug/1

Manufacturer

Hikma Pharmaceuticals USA Inc.

NDC

00143124001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DIGOXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA077002

On Market Since

10/30/2007

Pharmacological Classes

Cardiac Glycoside
Cardiac Glycosides

Price History

1W

0.0%

1M

+4.2%

3M

+4.4%

6M

+4.7%

1Y

-17.5%

3Y

-31.8%

5Y

-60.6%

All

+10.3%

Generic Alternatives

Save up to 6%

6 alternatives • Same active ingredient

DIGOXIN 0.125 MG TABLET
Generic
16714059002•NorthStar Rx LLC
$0.1106
Save 6%
DIGOXIN 125 MCG TABLET
Generic
69238199101•Amneal Pharmaceuticals NY LLC
$0.1173
DIGOXIN 125 MCG TABLET
Generic
00143124010•Hikma Pharmaceuticals USA Inc.
$0.1173
DIGOXIN 125 MCG TABLET
Generic
00904592161•Major Pharmaceuticals
$0.1173
DIGOXIN 125 MCG TABLET
Generic
82685020101•Oliva Therapeutics, LLC
$0.1173
DIGOXIN 0.125 MG TABLET
Generic
57664043788•Sun Pharmaceutical Industries Inc.
$0.1173

Related Drugs

Same classification

DIGOXIN 125 MCG TABLET
Generic
00115981101•Amneal Pharmaceuticals of New York LLC
$0.3074
per EA
DIGOXIN 125 MCG TABLET
Generic
00115981103•Amneal Pharmaceuticals of New York LLC
$0.3074
per EA
DIGOXIN 250 MCG TABLET
Generic
00115982201•Amneal Pharmaceuticals of New York LLC
$0.3183
per EA
DIGOXIN 250 MCG TABLET
Generic
00115982203•Amneal Pharmaceuticals of New York LLC
$0.3183
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy